# OnCo record nct00703820 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct00703820/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct00703820", "NCT00703820" ;
  schema:name "Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia"@en ;
  schema:description "A phase 3 trial of Cytarabine, Daunorubicin, Etoposide and Clofarabine in Acute myeloid leukaemia, run by St. Jude Children's Research Hospital, completed."@en ;
  schema:url <https://onco.cc/trials/nct00703820/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00703820> ;
  onco:status "completed" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/aml/> ;
  onco:drugs <https://onco.cc/drugs/cytarabine/>, <https://onco.cc/drugs/daunorubicin/>, <https://onco.cc/drugs/etoposide/>, <https://onco.cc/drugs/clofarabine/> .
